StatSure Diagnostic Systems (SSUR) Stock Price, News & Analysis

Company Overview

StatSure Diagnostic Systems, Inc. is a U.S.-based medical device company focused on point-of-care diagnostic solutions for monitoring kidney function. Its core offering is the STAT-SURE® Blood Urea Nitrogen (BUN) System, which provides clinicians with rapid, quantitative measurements of BUN using a compact analyzer and disposable test strips. This technology is designed to deliver critical renal function data within minutes, facilitating timely treatment decisions in outpatient dialysis centers, physician offices and other healthcare settings.

The STAT-SURE BUN System consists of a handheld instrument, single-use reagent strips and a proprietary calibration solution. Blood samples are obtained via a simple finger prick, and results are displayed in less than 60 seconds, removing the need for centralized laboratory testing and reducing patient turnaround time. StatSure complements its hardware and consumables with technical support, user training and quality-control products to help customers maintain compliance with industry regulations and ensure consistent, accurate performance.

Incorporated in the mid-1980s and headquartered in San Diego, California, StatSure Diagnostic Systems has built distribution relationships across North America, with select partnerships in Europe and other international markets. While operating as a small-cap company trading on the OTC market, StatSure continues to pursue product development initiatives and regulatory clearances aimed at expanding its presence in the rapidly growing point-of-care diagnostics arena.

Key Stats

• Today's Range: $0.0002 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0002 to $0.0002
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SSUR Stock Analysis - Frequently Asked Questions

How have SSUR shares performed this year?

StatSure Diagnostic Systems' stock was trading at $0.0002 on January 1st, 2025. Since then, SSUR stock has increased by 0.0% and is now trading at $0.0002.

How do I buy shares of StatSure Diagnostic Systems?

Shares of SSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:SSUR
• CIK: N/A
• Web: www.statsurediagnostics.com
• Phone: (917) 417-4489
• Fax: 718-228-2522
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -0.99